• <table id="gigg0"></table>
  • west china medical publishers
    Author
    • Title
    • Author
    • Keyword
    • Abstract
    Advance search
    Advance search

    Search

    find Author "李悠然" 2 results
    • A preliminary clinical efficacy analysis of local injection of high concentration of glucose when removing setons of perianal fistulizing in Crohn’s disease

      Objective To explore the effect of local injection of high concentration of glucose when removing setons of perianal fistulizing in Crohn’s disease (CD). Methods Thirty cases of CD combined with anal fistula admitted to the Affiliated Hospital of Nanjing University of Chinese Medicine from August 2015 to July 2017 were collected prospectively, 12 cases were divided into experimental group and 18 cases were divided into control group. Cases of the experimental group received demolition of drainage seton+IFX+local injection of high concentration of glucose treatment, cases of the control group received the drainage setons removing+IFX only. Before treatment, and at 6, 14, 22, and 30 weeks after IFX treatment, the laboratory indicators of the 2 groups were detected, and BMI, Crohn’s diseaseactivity index (CDAI), perianal disease activity index (PDAI), and clinical efficacy were evaluated. Results Therewas no significant difference on the group effect and interaction of group and time (P>0.05), but time (P<0.05). Both in the experimental group and the control group, compared with before treatment group, the counts of WBC and platelet, levels of C reaction protein (CRP) and erythrocyte sedimentation rate (ESR), CDAI, and PDAI at 6 months after IFX therapy decreased and maintained at the latter period, but the level of hemoglobin (Hb) and BMI increased at 6 weeks after IFX therapy and maintained at the latter period. On the clinical effect, there was no significant difference at the time points of 14, 22, and 30 weeks of IFX therapy (P>0.05). Conclusion The treatment of local injection of high concentration of glucose when removing setons has not shown any positive effect to CD combined with anal fistula, this conclusion needs to be further studied.

      Release date:2018-06-15 10:49 Export PDF Favorites Scan
    • 保留括約肌掛線引流術聯合英夫利昔單抗治療肛周瘺管型克羅恩病的短期臨床療效

      目的 總結保留括約肌掛線引流術聯合英夫利昔單抗(infliximab,IFX)治療肛周瘺管型克羅恩病(Crohn disease,CD)的短期臨床療效。 方法 回顧性分析江蘇省中醫院肛腸科于 2010 年 3 月至 2011 年 6 月期間收治的接受保留括約肌掛線引流術聯合 IFX 治療的 20 例肛周瘺管型 CD 患者的臨床資料,治療方案為降階梯治療。在第 0、2 及 6 周分別給予 5 mg/kg IFX 靜脈注射誘導治療,隨后給予每 8 周 1 次、共 3 次的 IFX 維持治療(5 mg/kg),共計 6 次。于治療前和第 0、6 及 30 周治療后評估克羅恩病活動指數(CDAI)、肛周克羅恩病活動指數(PCDAI)、治療效果及瘺管閉合情況,并開展實驗室檢測。 結果 ① CDAI 和 PCDAI:與治療前比較,第 0、6 及 30 周的 CDAI 和 PCDAI 均較低(P<0.05)。② 瘺管閉合:第 0 周時,18 例瘺管部分閉合,2 例無效;第6 周時,16 例瘺管完全閉合,4 例部分閉合;第 30 周時,16 例瘺管完全閉合,1 例部分閉合,3 例復發。③ 實驗室檢查:與治療前比較,第 0、6 及 30 周的 C-反應蛋白(CRP)水平、紅細胞沉降率(ESR)、血小板計數、中性粒細胞百分比及白細胞計數均較低(P<0.05),第 6 周和第 30 周的血紅蛋白水平較高(P<0.05)。④ 不良反應:治療過程中 3 例次發生不良反應。 結論 保留括約肌掛線引流術聯合 IFX 降階梯治療對肛周瘺管型 CD 有效。

      Release date:2017-11-22 03:58 Export PDF Favorites Scan
    1 pages Previous 1 Next

    Format

    Content

  • <table id="gigg0"></table>
  • 松坂南